Scientists test if new Weight-Loss drugs slow down your stomach
NCT ID NCT06801015
Summary
This study aims to understand how two weekly injectable medications for obesity—semaglutide and tirzepatide—affect how the stomach works. Researchers will compare these drugs to a placebo in 30 adults with obesity, measuring stomach emptying, feelings of fullness, and body weight over 24 weeks of treatment. The goal is to learn how these medications help control weight by changing stomach function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.